EltaMD AI Market Strategy Report - Dermatologist Recommended Skin Care Brands

Answer Capsule

EltaMD holds a stable but modest position in AI-generated recommendations for dermatologist recommended skin care brands, with valid recommendation coverage of 32.4% in September 2026. The brand appears in 35.9% of qualified observations but converts only a portion of that presence into actual recommendations, and its top-three rate sits at 9.7%. EltaMD's clearest strength is its rank-one performance relative to its coverage tier, while its clearest weakness is a recommendation profile that has not advanced despite stable presence. The biggest opportunity lies in converting existing visibility into stronger recommendation placement across high-intent skin care prompts.

Who This Report Is For

This report is for EltaMD's brand, marketing, and digital strategy teams tracking how AI search and assistant platforms recommend dermatologist approved skin care brands at the point of buyer consideration.

Report Card

Executive Summary

EltaMD holds a stable but modest position in AI-generated recommendations for dermatologist recommended skin care brands. The brand appeared in 273 of 760 qualified observations in September 2026, a presence rate of 35.9%, and received 246 valid recommendations, a coverage rate of 32.4%. This places EltaMD eighth among the ten tracked brands, ahead of Eucerin and Differin but well behind the category leaders.

The benchmark shows EltaMD with 261 positive mentions, 12 neutral mentions, and no negative mentions, producing a net sentiment score of 0.956. The absence of negative framing is a genuine strength, but the brand's challenge is not sentiment. It is recommendation conversion. EltaMD converts presence into valid recommendations at a rate consistent with its tier, yet its top-three rate of 9.7% and rank-one rate of 2.9% show that when the brand is recommended, it rarely leads the answer.

EltaMD's strongest platform signal came from ChatGPT, where the brand achieved its highest rank-one rate at 5.8%. Its weakest platform performance was on Gemini, where EltaMD recorded a 1.0% rank-one rate and a 28.1% valid recommendation coverage. The brand's coverage movement across the three-month series was minimal, with September coverage of 32.4% nearly identical to the July baseline of 33.1%, though August showed a temporary rise to 37.1% that did not hold.

The evidence suggests EltaMD is present in AI conversations about dermatologist recommended skin care but is not advancing into the top recommendation positions where buyer choice is most concentrated. The brand's stable presence without improving placement points to a positioning gap rather than a visibility gap.

What EltaMD Is Winning

Questions This Section Answers

• What evidence-backed strengths does EltaMD show in AI recommendations?
• How does EltaMD's rank-one rate compare with brands that have higher overall coverage?

EltaMD's clearest evidence-backed win is its rank-one rate relative to its coverage tier. At 2.9%, EltaMD leads the brands ranked below it and outperforms Cetaphil, Neutrogena, and Eucerin on first-position recommendations despite lower overall coverage than Cetaphil and Neutrogena. This suggests that when EltaMD is recommended, it occasionally earns the lead position rather than appearing only as a secondary option.

The brand also maintains a clean sentiment profile. With zero negative mentions across 273 appearances, EltaMD avoids the cautionary framing that can undermine recommendation quality. Its net sentiment score of 0.956 reflects consistently positive or neutral treatment in AI responses.

EltaMD's strongest platform performance came on ChatGPT, where it achieved a 5.8% rank-one rate and a 20.9% valid recommendation coverage. This was the brand's best first-position performance on any platform and indicates a pocket of recommendation strength in conversational assistant responses.

Where EltaMD Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How wide is the gap between EltaMD's presence and its recommendation prominence?
• Where do EltaMD's platform-level recommendation gaps appear?

EltaMD's most significant gap is the distance between its presence and its recommendation prominence. The brand appears in 35.9% of qualified observations but reaches the top three in only 9.7% and leads the recommendation in only 2.9%. This means EltaMD is frequently mentioned as context or as a secondary option rather than being positioned as the answer.

The comparison with category leaders is stark. CeraVe holds a 64.2% top-three rate and a 45.3% rank-one rate, while La Roche-Posay holds a 55.3% top-three rate and a 15.5% rank-one rate. EltaMD's average recommended rank of 3.78 places it well outside the top-three positions that capture the strongest buyer attention.

Platform-level gaps are also visible. On Gemini, EltaMD's valid recommendation coverage fell to 28.1%, below its overall average, and its rank-one rate dropped to 1.0%. On Perplexity, the brand recorded a 29.5% coverage rate and a 1.1% rank-one rate. These platforms show EltaMD present but not recommended with the frequency or prominence it achieves elsewhere.

The August 2026 coverage rise to 37.1% that did not hold into September suggests EltaMD lacks the sustained source and citation support needed to convert temporary visibility gains into durable recommendation strength.

Biggest Opportunity

Questions This Section Answers

• What is EltaMD's clearest opportunity for improving AI recommendation placement?
• Which high-intent prompt types represent the strongest discovery moments for EltaMD?

EltaMD's clearest opportunity is converting its existing presence into stronger recommendation placement on prompts where dermatologist recommendation is the deciding factor. The brand already appears in more than a third of qualified observations with a clean sentiment profile, which means the raw material for recommendation growth exists.

The path forward is to strengthen the public evidence layer that supports EltaMD's inclusion as a lead recommendation rather than a secondary mention. Prompts such as "What sunscreen do dermatologists recommend for the face?" and "mineral sunscreen for face" represent high-intent discovery moments where EltaMD's dermatologist association should carry weight. Building owned content and citation sources that reinforce EltaMD's position in these specific conversations could move the brand from presence to prominence.

Competitive Landscape

Questions This Section Answers

• Where does EltaMD rank among the ten tracked brands by top-three rate?
• What does EltaMD's average recommended rank of 3.78 indicate about its recommendation placement?

CeraVe and La Roche-Posay hold dominant recommendation-stage strength in this category, with CeraVe leading on both coverage and first-position placement. Vanicream has emerged as the clear third-place brand following sustained gains, while EltaMD sits in the middle tier with brands that are present but not leading recommendations.

Average recommended rank covers rank-eligible recommendations only.

The table shows EltaMD positioned eighth by top-three rate but with a rank-one rate that exceeds several brands with higher overall coverage. The brand's average recommended rank of 3.78 is comparable to Vanicream's 3.75, yet Vanicream reaches the top three more than twice as often. This indicates EltaMD's recommendations cluster just outside the top-three threshold, where buyer attention is weaker.

Prompt Evidence

ChatGPT / Brand Recommendation Prompt: "What is the best face wash for Accutane?" Result: EltaMD appeared in the response but did not secure a top-three recommendation position, with CeraVe and La Roche-Posay capturing the leading slots.

Gemini / Brand Recommendation Prompt: "What sunscreen do dermatologists recommend for the face?" Result: EltaMD was mentioned in the context of dermatologist-recommended options but received a 1.0% rank-one rate on this platform, indicating presence without lead recommendation status.

Copilot / Brand Recommendation Prompt: "What is the highest rated body lotion?" Result: EltaMD appeared in the response with positive framing but was not positioned as the lead recommendation, consistent with its 5.2% rank-one rate on Copilot.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map the specific prompt patterns where EltaMD appears but is not recommended, identifying which competitors capture the lead positions EltaMD could contest.

Phase 2: Recommendation Readiness Plan Prioritize the high-intent prompts where EltaMD's dermatologist association should carry the most weight, focusing on sunscreen and sensitive skin conversations.

Phase 3: Owned Answer Layer Buildout Develop owned content that directly answers the prompts where EltaMD is present but under-recommended, giving AI systems clearer material to cite.

Phase 4: Citation / Authority Layer Development Strengthen the external source footprint that supports EltaMD's dermatologist recommendation claims, particularly on platforms where coverage lags.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track whether presence gains convert into top-three and rank-one improvements across the six tracked platforms.

Why This Matters

AI-generated recommendations are becoming the buyer shortlist for dermatologist recommended skin care. When a shopper asks which brands dermatologists recommend, the brands that appear first in the AI answer capture the consideration that once went to search results and shelf placement.

EltaMD's presence in more than a third of these conversations is meaningful, but presence alone does not win the recommendation. The brands that lead the answer, CeraVe and La Roche-Posay, hold that position because their public evidence layer consistently supports first-position placement. For EltaMD, the next move is not more visibility. It is targeted correction of the prompt, page, and citation layers that determine whether the brand appears as the answer or merely as part of the context.

Core Metrics

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

For EltaMD, this calculation is (261 x 1 + 12 x 0 + 0 x -1) / 273, producing a score of 0.9560.

This score matters because unclassified mention counts are misleading. A brand can appear frequently in AI responses yet be mentioned as a cautionary example, a comparison anchor, or a secondary option rather than a genuine recommendation. Share of voice is a diagnostic metric, not a business outcome. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal, and counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because it separates brands that are recommended from brands that are merely referenced.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of EltaMD's AI visibility and recommendation performance, drawn from the LLM Authority Index AI Market Discovery Index for dermatologist recommended skin care brands. It is not a client implementation case study.
2. The reporting window is September 2026, with July 2026 and August 2026 referenced for movement analysis.
3. Six AI surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
4. The benchmark began with 800 prompt-surface observations and produced 760 qualified observations after excluding 15 irrelevant prompts and applying qualification rules.
5. Ten brands were tracked in the competitor universe: Aveeno, CeraVe, Cetaphil, Differin, EltaMD, Eucerin, La Roche-Posay, Neutrogena, SkinCeuticals, and Vanicream.
6. All qualified observations fell into the Brand Recommendation buyer-intent class, which captures discovery and consideration-stage questions seeking brand recommendations. The public benchmark does not yet contain qualified observations in the Pricing & Value or Multi-Brand Comparison classes.
7. Stage 0 extraction captured prompt-level observations including the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and citations where exposed.
8. A mention is defined as any appearance of a tracked brand in a qualified observation, regardless of whether the brand was recommended.
9. A valid recommendation is defined as an appearance where the brand is explicitly recommended or shortlisted in the AI response, distinct from a neutral reference or comparison anchor.
10. Brand-level percentages use the 760 qualified observations as the public denominator, not the 800 raw prompt-surface observations collected.
11. The public benchmark does not measure market share, sales attribution, organic-search ranking outside AI surfaces, social mention volume, or private channels. Metric movements record change rather than explaining cause.
12. Small-count movements affect brands such as Differin more than larger brands, and month-over-month movement identifies changes worth investigating rather than establishing causation.

See How AI Is Recommending Your Brand

The public benchmark shows where EltaMD stands in AI-generated recommendations, but the aggregate percentages hide the specific prompts, platforms, and competitor displacements that determine buyer choice. A company-level AI visibility audit maps those patterns into a prioritized strategy for converting presence into recommendation strength.